ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
ESTABLISHMENT LABS HOLDINGS INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$58.26−0.92 (-1.55%)
Close on Oct 19, 2026
- Market cap
- $1.75B
- P/E (TTM)
- –
- Dividend yield
- –
ESTABLISHMENT LABS HOLDINGS INC. revenue by segment
By business segment
By product or service
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| EMEA (Europe / Middle East / Africa) | $91.05M | $78.21M | $80.15M | $62.42M | $57.91M | – | – | 43.1% | +16.4% |
| North America | $45.56M | $4.41M | $2.16M | $995.00K | – | – | – | 21.6% | +933.0% |
| Latin America | $39.93M | $35.00M | $48.89M | $52.44M | $38.23M | $21.51M | $27.99M | 18.9% | +14.1% |
| Asia-Pacific | $34.54M | $48.41M | $33.95M | $45.84M | $29.68M | – | – | 16.4% | -28.6% |
| Europe | – | – | – | $48.70M | $51.91M | $37.67M | $36.21M | – | – |
| Asia-Pacific/Middle East | – | – | – | $59.56M | $35.68M | $24.99M | $24.82M | – | – |
| Other | – | – | $2.16M | $995.00K | $866.00K | $511.00K | $540.00K | – | – |
From the segment and revenue-disaggregation notes of Establishment Labs's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.